Ex-Raymond James exec sues, says he was fired after chemo

A former executive at Raymond James & Associates Inc. sued the company for $6 million, claiming he was fired after falling asleep as a result of chemotherapy.
JUN 08, 2010
By  Bloomberg
A former executive at Raymond James & Associates Inc. sued the company for $6 million, claiming he was fired after falling asleep as a result of chemotherapy. Stephen Fredericks, who was a managing director of sales trading, filed the complaint today in New York state Supreme Court in Manhattan. Fredericks, who worked for Raymond James from 2002 to 2009, said he underwent chemotherapy in 2008 after being diagnosed with lymphoma. As a side effect, he occasionally “spontaneously fell asleep,” he said, and was told that if he nodded off, he couldn't continue to work. He went on disability in May 2009 and was terminated that July, according to the complaint. “If you fall asleep again, I'm going to have to get rid of you or you will have to go onto disability,” Fredericks claims his supervisor told him, according to the filing. Meanwhile, the complaint says, another sales trader with no medical disability fell asleep at the trading desk. “This sales trader also viewed pornography on his computer and he was not fired until after” Fredericks raised his claims, according to the complaint. Fredericks, who said his overall business grew from $3.5 million to $4 million in 2008 while working with his medical disability, claims he is owed back pay, unpaid commission and bonuses, benefits and interest in the amount of $3 million. He also is seeking $3 million in damages. Anthea Penrose, a spokeswoman for St. Petersburg, Florida- based Raymond James Financial Inc., declined to comment. The case is Stephen Fredericks v. Raymond James and Associates Inc., 107281-2010, New York state Supreme Court (Manhattan).

Latest News

The 2025 InvestmentNews Awards Excellence Awardees revealed
The 2025 InvestmentNews Awards Excellence Awardees revealed

From outstanding individuals to innovative organizations, find out who made the final shortlist for top honors at the IN awards, now in its second year.

Top RIA Cresset warns of 'inevitable' recession amid tariff uncertainty
Top RIA Cresset warns of 'inevitable' recession amid tariff uncertainty

Cresset's Susie Cranston is expecting an economic recession, but says her $65 billion RIA sees "great opportunity" to keep investing in a down market.

Edward Jones joins the crowd to sell more alternative investments
Edward Jones joins the crowd to sell more alternative investments

“There’s a big pull to alternative investments right now because of volatility of the stock market,” Kevin Gannon, CEO of Robert A. Stanger & Co., said.

Record RIA M&A activity marks strong start to 2025
Record RIA M&A activity marks strong start to 2025

Sellers shift focus: It's not about succession anymore.

IB+ Data Hub offers strategic edge for U.S. wealth advisors and RIAs advising business clients
IB+ Data Hub offers strategic edge for U.S. wealth advisors and RIAs advising business clients

Platform being adopted by independent-minded advisors who see insurance as a core pillar of their business.

SPONSORED Compliance in real time: Technology's expanding role in RIA oversight

RIAs face rising regulatory pressure in 2025. Forward-looking firms are responding with embedded technology, not more paperwork.

SPONSORED Advisory firms confront crossroads amid historic wealth transfer

As inheritances are set to reshape client portfolios and next-gen heirs demand digital-first experiences, firms are retooling their wealth tech stacks and succession models in real time.